Get started
Author

Željko P. Mijušković

Observed names: Mijušković Željko, Z. Mijuskovic, Z. Mijušković, Z.P. Mijuskovic, Zeljko Mijuskovic, Zeljko P. Mijuskovic, Z̆P Mijušković, Ž. Mijušković, Željko Mijušković
ORCID: 0000-0003-0924-1719
Observed ORCID: 0000-0003-0924-1719
OpenAlex ID: A5036225228
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023
2023 · Ketty Peris, Maria Concetta Fargnoli, et al. · European Journal of Cancer · 372
PDF
Association Between Oxidative Stress and Melanoma Progression
2017 · Jelena Pantic Bisevac, Mirjana Djukic, et al. · Journal of Medical Biochemistry · 45
PDF
Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline – update 2024
2025 · Philippe Saiag, Celeste Lebbe, et al. · European Journal of Cancer · 38
PDF
Melanoma risk is associated with vitamin D receptor gene polymorphisms
2014 · Katarina Zeljic, Lidija Kandolf-Sekulovic, et al. · Melanoma Research · 35
Morphological features of naevoid melanoma: results of a multicentre study of the International Dermoscopy Society
2014 · C. Longo, S. Piana, et al. · British Journal of Dermatology · 29
PDF
Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society
2022 · Félix Pham, Amélie Boespflug, et al. · Journal of the American Academy of Dermatology · 28
PDF
A subpopulation that may correspond to granulocytic myeloid-derived suppressor cells reflects the clinical stage and progression of cutaneous melanoma
2015 · Ivan Stanojevic, Karolina Miller, et al. · International Immunology · 24
PDF
Persistent erythema multiforme: a report of three cases
2001 · MD Pavlović, DM Karadaglić, et al. · Journal of the European Academy of Dermatology and Venereology · 23
DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients
2019 · Helena Maric, Gordana Supic, et al. · Melanoma Research · 16
Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial
2023 · E. Livingstone, H. Gogas, et al. · European Journal of Cancer · 15
High Interleukin 27 Production is Associated with Early Clinical Stage and Localized Disease in Patients with Melanoma
2016 · Jelena Pantic Bisevac, Ivan Stanojevic, et al. · Journal of Medical Biochemistry · 9
PDF
Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF V600 -positive melanoma: Interim analysis of the ImmunoCobiVem study.
2022 · Dirk Schadendorf, Helen Gogas, et al. · Journal of Clinical Oncology · 8
Association of vascular endothelial growth factor expression with patohistological parameters of cutaneous melanoma
2016 · Milomir Gacevic, Milena Jovic, et al. · Vojnosanitetski pregled · 7
PDF
Lymphoscintigraphy and sentinel lymph node biopsy, in cutaneous melanoma staging and treatment decisions.
2015 · Ljiljana Jaukovic, Goran Sijan, et al. · PubMed · 7
Five and 10-year evolution of longitudinal melanonychia appearing before the age of 5: A multicenter prospective cohort study from the International Dermoscopy Society
2025 · Félix K. Pham, Bengü Nisa Akay, et al. · Journal of the American Academy of Dermatology · 5
Early switch from run-in with targeted to immunotherapy in advanced BRAF-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial
2025 · E. Livingstone, H.J. Gogas, et al. · ESMO Open · 5
PDF
Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia: The Melanoma Focus Study
2014 · Lidija Kandolf-Sekulovic, Nada Babovic, et al. · Vojnosanitetski pregled · 5
PDF
Etiology and pathogenesis of basal cell carcinoma
2013 · Željko P. Mijušković · Serbian Journal of Dermatology and Venerology · 5
PDF
National Guidelines for the Treatment of Atopic Dermatitis
2016 · Svetlana Popadić, Mirjana Gajić-Veljić, et al. · Serbian Journal of Dermatology and Venerology · 4
PDF
Serbian Association of Dermatovenereologists’ Guidelines for the Diagnosis and Treatment of Psoriasis
2016 · Željko P. Mijušković, Lidija Kandolf-Sekulović, et al. · Serbian Journal of Dermatology and Venerology · 4
PDF
LBA45 Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial
2024 · D. Schadendorf, H. Gogas, et al. · Annals of Oncology · 3
PDF
Overgrowth of Undifferentiated Pleomorphic Sarcoma During Vismodegib Treatment of Locally Advanced Basal Cell Carcinosarcoma
2020 · Željko Mijušković, Dimitrije Brašanac, et al. · JCO Oncology Practice · 3
Pyoderma Vegetans – a Case Report
2017 · Ljubica Jevremović, Ivana Ilijin, et al. · Serbian Journal of Dermatology and Venerology · 3
PDF
Dress Syndrome - A Case Report
2016 · Zorana Kremić, Željko P. Mijušković, et al. · Serbian Journal of Dermatology and Venerology · 3
PDF
Interferon alpha-induced reduction in the values of myeloid-derived suppressor cells in melanoma patients
2015 · Ivan Stanojevic, Milomir Gacevic, et al. · Vojnosanitetski pregled · 3
PDF
Works count: 53
Citation count: 715
H-index: 10
I10-index: 10
Year
Topic
Type